SAR-125844 | B2510

SAR-125844 is a potent, selective, reversible and ATP-competitive c-MET inhibitor, with an IC₅₀ of 4.2 nM. Displays inhibition of MET autophosphorylation in cell-based assays. Upon intravenous administration, SAR-125844 binds to c-Met, thereby disrupting c-Met-mediated signal transduction pathways.This may result in cell growth inhibition in tumors that overexpress c-Met.

SAR-125844 is a potent, selective, reversible and ATP-competitive c-MET inhibitor, with an IC₅₀ of 4.2 nM. Displays inhibition of MET autophosphorylation in cell-based assays. Upon intravenous administration, SAR-125844 binds to c-Met, thereby disrupting c-Met-mediated signal transduction pathways.This may result in cell growth inhibition in tumors that overexpress c-Met.

B2510 | SAR-125844 DataSheet

Alternate Name/Synonyms: SAR125844; 1-(6-((6-(4-fluorophenyl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl)thio)benzo[d]thiazol-2-yl)-3-(2-morpholinoethyl)urea

Appearance: Crystalline solid

Formulation:

CAS Number: 1116743-46-4

Structure Available?: Yes

Peptide sequence: N/A

Salt Form: Yes

Molecular Formula: C₂₅H₂₃FN₈O₂S₂

Molecular Weight: 550.63

Cell-Permeable?: True

Purity: ≥98% by HPLC

Solubilities: >40 mg/ml in DMSO

Handling: Do not take internally. Wear gloves and mask when handling the product! Avoid contact by all modes of exposure.

Country of Origin: USA

Tag Line: A potent c-Met inhibitor

MDL Number:

PubChem CID: 25182860

SMILES: C1COCCN1CCNC(=O)NC2=NC3=C(S2)C=C(C=C3)SC4=NN=C5N4N=C(C=C5)C6=CC=C(C=C6)F

InChi: InChI=1S/C25H23FN8O2S2/c26-17-3-1-16(2-4-17)19-7-8-22-30-31-25(34(22)32-19)37-18-5-6-20-21(15-18)38-24(28-20)29-23(35)27-9-10-33-11-13-36-14-12-33/h1-8,15H,9-14H2,(H2,27,28,29,35)

InChi Key: ODIUNTQOXRXOIV-UHFFFAOYSA-N